Picture of Sharon Bio-Medicine logo

SHARONBIO Sharon Bio-Medicine Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareMicro Cap

Annual cashflow statement for Sharon Bio-Medicine, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

C2015
June 30th
2016
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M9 M12 M12 M12 M
Source:ARSARSPRESSPRESSPRESS
Standards:
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1,446-2,179140177190
Depreciation
Non-Cash Items37.2-120-12.9-4.57-16.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital3871,834-195-48.4137
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-835-31541.6230411
Capital Expenditures-109-14.7-43.2-45.1-49.9
Purchase of Fixed Assets
Other Investing Cash Flow Items8.259.634.7512.722.1
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-101-5.05-38.5-32.4-27.7
Financing Cash Flow Items-12.31030.2160.2740.228
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9712620.2160.2740.228
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash35.8-57.73.36197384